Osemwegie Emovon is a Nephrology physician affiliated with Medical University of South Carolina. OpenAlex indexes 27 publications with 412 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1007 Physicians Dr
Charleston, SC 294145746
Telephone
843-573-0499Provider last certified this registry record 13 Apr 2026.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20253 payments
- Otsuka America Pharmaceutical, Inc.Program year20252 payments
- Integra LifeSciences CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
50.4%Calcium channel blocker10.3%Amlodipine Besylate68%Nifedipine Er32%Part D≥70 patientsBeta blocker9.9%Carvedilol67%Metoprolol Tartrate25%Labetalol Hcl7%Part D<11 patients+ 13 more classes in this area
Metabolism & gastrointestinal
12.4%Proton pump inhibitor3.7%Omeprazole69%Pantoprazole Sodium31%Part D≥28 patientsCorticosteroid1.7%Prednisone100%Part D≥18 patients+ 9 more classes in this area
Other
10.7%Phosphate Binder7.8%Sevelamer Carbonate100%Part D≥70 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia2.9%Velphoro71%Auryxia29%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Brain MR imaging abnormalities in kidney transplant recipients.
PubMed
2005 - Treating Borderline Biopsies during Episodes of Renal Allograft Dysfunction: The Impact of Age and Ethnicity on Treatment Strategy and Outcome
Journal of Investigative Medicine
2005 - 213 TREATING BORDERLINE BIOPSIES DURING EPISODES OF RENAL ALLOGRAFT DYSFUNCTION: THE IMPACT OF AGE AND ETHNICITY ON TREATMENT STRATEGY AND OUTCOME
Journal of Investigative Medicine
2005 - Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease
Transplant Infectious Disease
2004
Similar KOLs
Other experts from the same institution or the same specialty.
Tanya Turan, MD
Medical University of South Carolina
Michael Zile, MD
Medical University of South Carolina
Don Rockey, MD
Medical University of South Carolina
William Creasman, MD
Medical University of South Carolina
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”